Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol.
D000328:Adult; D000493:Allopurinol / Q000009:adverse effects* / Q000494:pharmacology; D001344:Autopsy; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007669:Kidney Calculi / Q000139:chemically induced* / Q000473:pathology; D007682:Kidney Pelvis / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D014527:Uric Acid / Q000096:biosynthesis; D014750:Vincristine / Q000627:therapeutic use; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors; D014970:Xanthines / Q000378:metabolism*
D014970:Xanthines; D014527:Uric Acid; D014750:Vincristine; D000493:Allopurinol; D003520:Cyclophosphamide; D014969:Xanthine Oxidase; D011241:Prednisone